There are currently over 450,000 cancer survivors between 19 and 39 years of age. In 2005, 1-3 1,372,910 people were diagnosed with cancer and 4% (~55,000 cases) were under 35 years of age. 2, 3 Breast cancer, cervical cancer, non-Hodgkin's lymphoma, leukemia, and melanoma are the most common incident cancers in people under 40 years of age.
agencies may reject cancer survivors based on their health histories, even with recommendations from physicians reporting the survivor is cancer-free. 13 Studies of cancer patients report that loss of fertility is an immense concern that may cause great distress. 4, [7] [8] [9] 11, [14] [15] [16] This mirrors findings in studies of infertile non-cancer populations as well those cancer survivors whose quality of life is often affected by discontent from the grief of infertility.
12,17

Fertility Preservation Options
Male cancer patients who undergo chemotherapy may experience toxicity to the gonads that may lead to permanent spermatogenesis impairment. 18, 19 In general, men have had a longer history of availability of fertility preservation options, particularly semen cryopreservation.
With the recent advances in cryopreservation of testicular tissue and semen, samples can be taken from most post-pubertal males. ASCO and the American Society of Reproductive Medicine (ASRM) recommend that all male cancer patients be offered the option of semen cryopreservation and referred to a licensed facility prior to the initiation of cancer treatment. 7, 20 For women, fertility and cancer encompass more complex issues. The procedures associated with embryo and oocyte cryopreservation can take several weeks to be performed, which may lead to a delay in cancer therapy-a less appealing option for those diagnosed with advanced-stage cancers. 4, 7, 10 ASCO provides a list of fertility preservation options for men and women accompanied by eligibility criteria and considerations. 
Patient-Provider Communication About Fertility Preservation
Despite evidence that patients want information about future fertility, the existing research finds large gaps between recommended and actual clinical practice related to the discussion of options with cancer patients.
A pilot study, 10 as well as a follow-up study, 22 revealed that patients are not well informed about available preservation options. Cancer survivors were queried about whether a healthcare provider had discussed the risk for infertility with them. Only 50% of survivors recalled receiving information from a healthcare provider about the risks of infertility from their treatment. 10, 22 Furthermore, <35% of the women in a study of breast cancer survivors recalled discussing the risks of pregnancy during or after cancer treatment with a healthcare provider. 23 In the past few years two leading professional organizations have issued guidelines specific to fertility preservation in cancer patients. In 2005, ASRM published guidelines specifically developed for oncologists about the discussion of options for young cancer patients. 20 In 2006, ASCO 4 published guidelines stating that "oncologists should address the possibility of infertility with patients treated during their reproductive years and be prepared to discuss possible fertility preservation options or refer appropriate and interested patients to reproductive specialists.
Clinician judgment should be employed in the timing of raising this issue, but discussion at the earliest possible opportunity is encouraged." Until this time, there had been no official practice guidelines for such discussions, which may have contributed to the current lack of discussion about fertility preservation between patients and providers. Despite lack of patient recall about discussion of infertility, by contrast, a recent national survey of US oncologists showed that 74% said they always discuss fertility preservation with their patients of childbearing age. 25 Several factors may contribute to lack of discussion by oncologists, including the physician's knowledge and attitudes toward fertility preservation or comfort with the topic. [24] [25] [26] Physicians may feel that treating the cancer is the highest priority for cancer care. [24] [25] [26] [27] A physician may bring up the topic of fertility, but patients can be overwhelmed by their diagnosis and only want to focus on surviving the disease or not recall that the topic was mentioned. [24] [25] [26] Physicians may not want to press the issue of preservation with patients whose sole focus at the time of diagnosis is survival. 24, 26 Physicians may also be reluctant to have this discussion with patients who have a poor prognosis for survival. [24] [25] [26] [27] The issue of a physician's personal/ethical concerns with posthumous parenting have been identified in previous studies as a deterrent to discussing fertility. Although some physicians disagree with posthumous parenting, ASRM recommends that physicians do not deny patients fertility preservation information based on their personal beliefs.
